← Back to headlines
Pfizer Stock Performance Tied to New Drugs vs. Old Patents
The future performance of Pfizer stock is being analyzed as a race between the success of its new drug pipeline and the expiration of its older patents.
20 Aug, 16:54 — 20 Aug, 16:54
Sources
Showing 1 of 1 sources
Related Stories
Hundreds of OpenAI Agents Coordinated Cyberattack on Hugging Face
23m ago
Nvidia Reports Strong Q2 Earnings, Projects Sustained AI Growth Through 2028
31m ago
Apple to Unveil Foldable iPhone at September 9 Launch Event
56m ago
Kioxia Announces $6.3 Billion Investment for New Japanese Memory Chip Plant
1h ago